Presspart reveals its Quantum Dose Indicator at Pharmapack North America on 9-10 June in New York

The Presspart Group (Contact), a division of the Heitkamp & Thumann Group, will present the QuantumTM Dose Indicator and other product solutions at booth 4019 at this years Pharmapack North America. This will be the debut of the low cost indication solution for the North American market.

Knowing the current filling level of a metered dose inhaler (MDI) can be of critical importance to the patient. Presspart’s patented Quantum™ end-of-life indicator represents a low cost solution to this problem. The Quantum™ dose indicator is integrated into the MDI can and is compatible with all current filling and packaging lines. The Quantum™ system features no additional mechanical or electronic components and is a fail-safe, robust and reliable end-of-life indication system.

For further information regarding Pressparts Pharmapack participation click here.